Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0Â ng/mL to 13.0Â ng/mL

Clinical utility of serum folate measurement in tertiary care patients: Argument for revising reference range for serum folate from 3.0Â ng/mL to 13.0Â ng/mL

Objective: Assess the need for folate testing, frequency of corrective action, and determine reference level for serum folate. Methods: Serum folate levels in 5313 samples from 4448 patients, and clinical data were reviewed for patient characteristics and for (a) evidence of corrective action in pat...

Full description

Bibliographic Details
Main Authors:	Gurmukh Singh, Hana Hamdan, Vivek Singh
Format:	Article
Language:	English
Published:	Elsevier 2015-04-01
Series:	Practical Laboratory Medicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352551715000086

Similar Items

The likelihood of having serum level of PSA of ≥4.0 ng/mL and ≥10.0 ng/mL in non-obese and obese Nigerian men with LUTS
by: Patrick Temi Adegun, et al.
Published: (2015-07-01)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Katia R. Leite, et al.
Published: (2008-06-01)

Strategy for prostate cancer patients with low prostate specific antigen level (2.5 to 4.0 ng/ mL)
by: J.H. Chung, et al.
Published: (2020-07-01)

Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
by: Yuanyuan Guo, et al.
Published: (2018-11-01)

The association of markers of oxidative-inflammatory status with malnutrition in hemodialysis patients with serum ferritin lower than 500 ng/mL
by: Simone Gonçalves de Almeida, et al.
Published: (2013-03-01)

Serum levels of unconjugated bisphenol A are below 0.2 ng/ml in Swedish nursing women when contamination is minimized
by: Irina Gyllenhammar, et al.
Published: (2014-03-01)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
by: Alexander I. Hinev, et al.
Published: (2012-01-01)

Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML
by: Mustafa Sofikerim, et al.
Published: (2007-01-01)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
by: I. Vukovic, et al.

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
by: Zhila Maghbooli, et al.
Published: (2020-01-01)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml -1 and 10.1-20.0 ng ml -1 : a multicenter study
by: Yu-Rong Lin, et al.
Published: (2015-06-01)

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis
by: Kan HC, et al.
Published: (2017-06-01)

Decision Tree Analysis for Prostate Cancer Prediction in Patients with Serum PSA 10 ng/ml or Less
by: Pantic Damjan N, et al.
Published: (2020-03-01)

The association of markers of oxidative-inflammatory status with malnutrition in hemodialysis patients with serum ferritin lower than 500 ng/mL Associação dos marcadores do estado oxidativo e inflamatório com a desnutrição em pacientes hemodialisados com ferritina menor do que 500 ng/mL
by: Simone Gonçalves de Almeida, et al.
Published: (2013-03-01)

Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4–10 ng/mL
by: Chen N, et al.
Published: (2017-07-01)

Prognosis of patients with prostate cancer and middle range prostate - specific antigen levels of 20 – 100 ng / mL
by: Hiroaki Iwamoto, et al.

Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection.
by: PLOS ONE Editors
Published: (2020-01-01)

Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.
by: Rui Chen, et al.
Published: (2015-01-01)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Alexandros Fiamegos, et al.

Compare prostate cancer detection rate between 12- and 18-core prostate biopsy in patients with normal dre and serum psa level of 4.0-20.0 ng/ml
by: Bo-Ren Wang, et al.
Published: (2015-06-01)

Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice
by: Kyung Tak Oh, et al.
Published: (2020-01-01)

Predictive factors of prostate cancer diagnosis with PSA 4.0–10.0 ng/ml in a multi-ethnic Asian population, Malaysia
by: Raymond Shi Liang Yii, et al.
Published: (2020-01-01)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
by: Gokhan Koc, MD, et al.
Published: (2017-01-01)

The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL
by: Cem Yücel, et al.
Published: (2018-06-01)

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10 ng/mL
by: Yongqiang Zhou, et al.
Published: (2017-01-01)

Automated Source Code Structure Feedback Using srcML and RelaxNG
by: Sedgwick, Brandon M.
Published: (2013)

Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients.
by: Hee-Yeon Jung, et al.
Published: (2020-01-01)

Prostate Health Index (PHI) improves prostate cancer detection at initial biopsy in Taiwanese men with PSA 4–10 ng/mL
by: Po-Fan Hsieh, et al.
Published: (2018-08-01)

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
by: Hugo A. Socrates Castro, et al.

PSA levels of 4.0 - 10 ng/ml and negative digital rectal examination: antibiotic therapy versus immediate prostate biopsy
by: Avraham Shtricker, et al.
Published: (2009-10-01)

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
by: Umezawa Rei, et al.
Published: (2011-11-01)

The Diagnostic Values of Pretreatment Serum Inflammation Markers and Lipoprotein in Men With Total Prostate-Specific Antigen Between 4 and 10 ng/ml
by: Guangping Li, et al.
Published: (2020-11-01)

The assessment of useful parameters for detecting prostate cancer patients with total serum prostate-specific antigen between 4 and 10ng/ml
by: Tsai Ming-Shun, et al.
Published: (2011)

Spermatozoa motility, viability, acrosome integrity, mitochondrial membrane potential and plasma membrane integrity in 0.25 mL and 0.5 mL straw after frozen-thawing in Hanwoo bull
by: Sung-Sik Kan, et al.
Published: (2020-12-01)

Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
by: Joongwon Choi, et al.
Published: (2020-11-01)

LC-MS/MS-Based Method for the Multiplex Detection of 24 Fentanyl Analogues and Metabolites in Whole Blood at Sub ng mL–1 Concentrations
by: Kraig E. Strayer, et al.
Published: (2018-01-01)

Prostate-specific antigen 10–20 ng/mL: A predictor of degree of upgrading to ≥8 among patients with biopsy Gleason score 6
by: Glen Denmer R. Santok, et al.
Published: (2017-03-01)

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
by: Christos Kalaitzis, et al.
Published: (2014-01-01)

Effect of Summer Sunshine Exposure on Vitamin D Status in Young and Middle Age Poles: Is 30 ng/mL Vitamin D Cut-Off Really Suitable for the Polish Population?
by: Magdalena Basińska-Lewandowska, et al.
Published: (2021-07-01)

Insights into the biogenesis of the human mitochondrial ribosomal large subunit – Characterisation of mL44 and mL45
by: Hanitsch, Elisa
Published: (2020)